- Home
- KOPN vs NMRA Comparison
KOPN vs NMRA Comparison
Compare KOPN & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KOPN
- NMRA
- Stock Information
- Founded
- KOPN 1984
- NMRA 2019
- Country
- KOPN United States
- NMRA United States
- Employees
- KOPN N/A
- NMRA N/A
- Industry
- KOPN Semiconductors
- NMRA
- Sector
- KOPN Technology
- NMRA
- Exchange
- KOPN Nasdaq
- NMRA Nasdaq
- Market Cap
- KOPN 255.1M
- NMRA 121.0M
- IPO Year
- KOPN 1992
- NMRA 2023
- Fundamental
- Price
- KOPN $1.58
- NMRA $0.84
- Analyst Decision
- KOPN Strong Buy
- NMRA Buy
- Analyst Count
- KOPN 3
- NMRA 8
- Target Price
- KOPN $2.58
- NMRA $9.29
- AVG Volume (30 Days)
- KOPN 3.1M
- NMRA 1.4M
- Earning Date
- KOPN 08-07-2025
- NMRA 08-05-2025
- Dividend Yield
- KOPN N/A
- NMRA N/A
- EPS Growth
- KOPN N/A
- NMRA N/A
- EPS
- KOPN N/A
- NMRA N/A
- Revenue
- KOPN $50,841,018.00
- NMRA N/A
- Revenue This Year
- KOPN $8.02
- NMRA N/A
- Revenue Next Year
- KOPN $20.99
- NMRA N/A
- P/E Ratio
- KOPN N/A
- NMRA N/A
- Revenue Growth
- KOPN 28.16
- NMRA N/A
- 52 Week Low
- KOPN $0.56
- NMRA $0.61
- 52 Week High
- KOPN $2.17
- NMRA $17.19
- Technical
- Relative Strength Index (RSI)
- KOPN 55.40
- NMRA 52.19
- Support Level
- KOPN $1.44
- NMRA $0.72
- Resistance Level
- KOPN $1.64
- NMRA $0.85
- Average True Range (ATR)
- KOPN 0.09
- NMRA 0.07
- MACD
- KOPN -0.02
- NMRA -0.01
- Stochastic Oscillator
- KOPN 53.85
- NMRA 62.35
About KOPN Kopin Corporation
Kopin Corp is a provider of high-performance application-specific optical solutions consisting of high-resolution microdisplays and optics, subassemblies, and headsets. It serves soldiers, avionics, armored vehicles training and simulation military applications, and others. Its product portfolio includes Microdisplays, Spatial Light Modulators, Optical Modules, Medical, Training, and Simulation. Geographically, it derives a majority of its revenue from the Americas and also has a presence in Asia-Pacific; Europe, and Other Countries.
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.